Technology transfer / Localization · GCC · Announced 12 Jun 2026
Menarini → ADCAN Pharma
ADCAN Pharma has signed with Menarini — one of Italy's largest privately held pharma groups — to locally manufacture and batch-release selected Menarini products in the UAE, the Italian company's first pharmaceutical localization initiative in the country.
Parties: Menarini (Italy) → ADCAN Pharma (United Arab Emirates)
- Deal type
- Technology transfer / Localization
- Value
- Undisclosed
- Territory
- United Arab Emirates
- Therapeutic area
- Multi-therapy
- Asset
- Local manufacture and batch release of selected Menarini pharmaceutical products in the UAE — Menarini's first pharmaceutical localization initiative in the country (products undisclosed)
- Announced
- 12 Jun 2026
Our analysis
Why this matters
Menarini's first localization initiative in the UAE landed at ADCAN's Abu Dhabi plant — months before the CPHI Milan deal wave made ADCAN a name in Gulf manufacturing. Signed on 12 June 2026 at ADCAN's facility with the Emirates Drug Establishment in attendance, the agreement makes ADCAN the local manufacturer and batch-release holder for selected Menarini products.
For CEOs: Menarini — one of Italy's largest privately held pharmaceutical groups — validated ADCAN as a localization partner before the October deals; this was the reference that made them credible.
The full analysis is free to read with a work email on this page.
Source: Zawya